Back to search

Dublin City University

Targeted neurotherapeutics for chronic inflammatory pain

Abstract

dc:description.abstract

The P2X purinoceptor 3 (P2X3) plays a crucial role in signalling leading to chronic inflammatory pain and, thus, the P2X3 receptor provides a proven target for its treatment. Botulinum toxin type A (BoNT/A) is a potentially promising candidate drug for use in this situation. Long-acting botulinum neurotoxin type D (BoNT/D) inhibits inflammatory pain peptide release from cultured sensory neurons evoked by K+, bradykinin or capsaicin. The purpose of this project is to develop single-chain antibody variable fragments (scFv) recognising extracellular domains of P2X3, for use as a targeting agent to deliver protease and translocation domains of BoNT/A and BoNT/D (LC-HN/A and LC-HN/D) to pain-signalling neurons. A rabbit scFv library was generated, and phage display was applied for anti-P2X3 scFv recombinant antibody selection. After five rounds of bio-panning, followed by polyclonal phage ELISA, monoclonal ELISA, cross reactivity analysis, competitive ELISA, western blotting and immunofluorescence staining, anti-P2X3-257 scFv clones with high specificity and affinity were successfully selected. The scFv gene was fused to BoNT/A and BoNT/D and expressed as a fusion protein in E. coli. After purification,this protein was shown to enter sensory neurons and to cleave its neuronal target, VAMP2. The efficacy of this therapeutic will be further evaluated using established capsaicin-induced or formalin-induced rat inflammatory pain models.

Degree

thesis:*
Name dc:type.qualificationname
phd
Level dc:type.qualificationlevel
doctoral
Grantor dc:publisher.institution
Dublin City University
Year dc:date.issued
2013

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Hui, Ma

Rights

Language dc:language
en

Chain of custody

source
Harvested from
Dublin City University
Base URL
doras.dcu.ie/cgi/oai2
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Hui, Ma. Targeted neurotherapeutics for chronic inflammatory pain. doctoral thesis, Dublin City University, 2013.